About the Authors
- Paul Gozzard
-
* E-mail: p.gozzard@nhs.net
Current address: Department of Neurology, Royal Hallamshire Hospital, Sheffield, United Kingdom
Affiliation Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
- Caroline Chapman
-
Affiliation Division of Medical Sciences & Graduate Entry Medicine, University of Nottingham, Royal Derby Hospital, Derby, United Kingdom
- Angela Vincent
-
Affiliation Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
- Bethan Lang
-
Affiliation Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
- Paul Maddison
-
Affiliation Division of Clinical Neuroscience, University of Nottingham, Queen’s Medical Centre, Nottingham, United Kingdom
Competing Interests
Dr Chapman reports grants and receives personal fees from OncoImmune Inc. Prof Vincent reports grants from NIHR and receives personal fees from Athena diagnostics. Prof Vincent is the named inventor on patent application WO/2010/046716 entitled ‘Neurological autoimmune disorders’. The patent has been licensed to Euroimmun AG for the development of assays for LGI1 and other VGKC-complex antibodies. Dr Lang is a coinventor and may also receive future royalties. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials. The authors have no other relevant declarations relating to employment, consultancy, patents, products in development or modified products. The other authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: PG CC AV BL PM. Performed the experiments: PG CC BL. Analyzed the data: PG AV BL. Contributed reagents/materials/analysis tools: PG CC AV BL. Wrote the paper: PG AV BL PM.